Dr Hirsch and Dr Larholt invited to NAS workshop

Eric NormanLEAPS, News

NEWDIGS Exutive Director Gigi Hirsch and Director of Research Kay Larholt were invited to participate in the National Academies of Science’s Envisioning a Transformed Clinical Trials Enterprise for 2030. This workshop is being … Read More

FoCUS Monthly Recap: January 2021

Eric NormanFoCUS, News

RESEARCH BRIEF Resource navigation challenges for patients and caregivers While the problem of finding system-wide, implementable precision financing models for curative and durable therapies involves all stakeholders, patients and caregivers … Read More

LEAPS Monthly Recap: December 2020

Eric NormanLEAPS, News

NEW MEMBER NEWDIGS welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project Collaboration to enhance the capacity of disease ecosystems for regimen optimization Cerevel Therapeutics, a company dedicated … Read More

FoCUS Monthly Recap: December 2020

Eric NormanFoCUS, News

IN THE MEDIAMark Trusheim coauthored the article “Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions” published in Science Direct: Drug Discovery Today, November 24, 2020. This review … Read More

FoCUS Monthly Recap: October 2020

Eric NormanFoCUS, News

WHITE PAPER Warranty Model: A potential precision financing solution for durable cell and gene therapies Durable cell and gene therapies are poised for rapid growth—posing transformative benefits for patients and … Read More

LEAPS Monthly Recap: October 2020

Eric NormanLEAPS, News

RESEARCH SPOTLIGHT Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, … Read More